Siren Biotechnology, pioneers of Universal AAV Immuno-Gene Therapy for Cancer, and Catalent Inc., the leader in enabling the development and supply of better treatments...
Phanes Therapeutics, Inc. (Phanes), a clinical stage biotech company focused on innovative drug discovery and development in oncology, announced that it has entered into...
Transforms Nuvation Bio into late-stage global oncology company with potential to become a commercial organization by the end of 2025
Nuvation Bio Inc., a late-stage,...
Company announces multi-year strategic partnership with AstraZeneca to accelerate early breast cancer evidence development and research.
PicnicHealth, a patient-centered health technology company, announced its entry...
New research in the June 2023 issue of JNCCN—Journal of the National Comprehensive Cancer Network found that when alectinib—a safe and effective small molecule kinase inhibitor used to...
